December 2025

126 Articles

No Section

The changing landscape of heart failure: translating management into the modern era

5 December 2025
Author(s): Cristina Madaudo, Wasyla Ibrahim, Daniela Noakes, Daniel Bromage, Gianfranco Sinagra, Theresa McDonagh, Antonio Cannata

Heart failure (HF) is a complex clinical syndrome associated with high morbidity and mortality, accounting for approximately 2 % of total healthcare expenditures. Despite advances in pharmacological... more

From networks of data to networks of care in clinical medicine: this is not artificial intelligence

24 November 2025
Author(s): Pierfrancesco Novielli, Roberto Bellotti, Mohamad Khalil, Piero Portincasa, Sabina Tangaro

The increasing availability of clinical, omic, and imaging data in clinical medicine opens unprecedented opportunities to uncover hidden patterns and mechanistic insights into disease. Available... more

Survival effect of early high-flow nasal oxygen after extubation: Statistical, methodological, and ethical concerns

11 November 2025
Author(s): Yukio Umeda

We read with great interest the article by Ishihara et al. evaluating the survival impact of early high-flow nasal oxygen (HFNO) following extubation in intensive care patients [1] Although the... more

Optimising the Caravaggio score: developing a more universally applicable and comprehensive venous thromboembolism risk stratification tool. Author’s reply

24 October 2025
Author(s): Maria Cristina Vedovati, Giancarlo Agnelli

Dear Editor, we thank Wang et al. for their suggestions on potential matters to optimize the Caravaggio score [1]. The recently published Caravaggio score was aimed to stratify the risk of recurrence... more

Serum transthyretin in ATTR-CM: A pragmatic biomarker edging toward prime time

25 September 2025
Author(s): Alberto Aimo, Vincenzo Castiglione, Giuseppe Vergaro

Over the last decade, transthyretin amyloid cardiomyopathy (ATTR-CM) has shifted toward earlier recognition and routine use of disease-modifying therapy, heightening the need for biomarkers that are... more

Renal outcomes following anticoagulation in atrial fibrillation: urgent need for randomized evidence

25 August 2025
Author(s): Costas Platanias, Ioannis Vasileiadis, Ilektra Oikonomopoulou, Elias Sanidas, Costas Thomopoulos

We read with interest the well-written meta-analysis by Adamou et al. [1], focused on studies of atrial fibrillation (AF) patients, investigating the comparative effect of direct oral anticoagulants... more

Beyond the Guidelines

Exporting integration: The southern European internist in the age of specialization

20 November 2025
Author(s): Mayka Freire, Bernardo Sopeña, Emilio Casariego-Vales

If fragmentation is today’s common clinical hazard, the question is which model of Internal Medicine is built to resist it.

Managing invasive fungal infections in critical illness: reflections on recent American Thoracic Society recommendations

16 October 2025
Author(s): Claudia Bartalucci, Jon Salmanton-García, Antonio Vena

The global burden of invasive fungal diseases (IFDs) continues to increase, particularly among critically ill patients, where mortality remains high —reaching up to 70 %— despite major advances in... more

Repositioning beta-blocker therapy after acute myocardial infarction

8 October 2025
Author(s): José A. Barrabés, Aitor Uribarri

Beta-blockers have long been prescribed for secondary prevention in patients with acute myocardial infarction (MI) after clinical trials performed in the 1980′s demonstrated that their use provided... more

Clinical Insights

Advances in syncope: Recent evidence and clinical implications

5 December 2025
Author(s): Giacomo Ramponi, Marco Paganuzzi, Monica Solbiati, Giorgio Costantino

The purpose of this article is the synthesis of the most relevant advances in syncope research over the last decade, bridging current practice with future directions across settings of care (... more

Commentary

A call to action: Bridging glucose monitoring and treatment gaps in inpatient diabetes care

5 December 2025
Author(s): Guillermo Umpierrez, Fernando Gomez-Peralta

Diabetes mellitus remains a major global health challenge, increasing clinical, social, and economic burdens on individuals and healthcare systems. In nearly every region of the world, the rising... more

The challenges of anemia management in cardiorenal disease

23 November 2025
Author(s): Elena Ratto, Francesca Viazzi, Elisa Russo

Chronic kidney disease (CKD) and heart failure (HF) are two highly prevalent chronic conditions that together contribute substantially to the global burden of disease. The coexistence of HF and CKD... more

Tezepelumab for severe asthma – an “all round” player

18 November 2025
Author(s): Ophir Freund, Hitasha Rupani, Brian Lipworth, Rory Chan

Many patients with severe asthma who were historically dependent on oral corticosteroids (OCS) for disease control have now entered a new era. Initiation of OCS has become an uncommon event, and many... more

Air pollution: A new avenue for a population-level approach to tackle metabolic dysfunction-associated steatotic liver disease (MASLD)?

28 October 2025
Author(s): Carel-Peter L. van Erpecum

In this issue of the European Journal of Internal Medicine, Di Ciaula et al [1] provide new insights into metabolic dysfunction-associated steatotic liver disease (MASLD) by looking into the... more

Perspective on Epicardial Adipose tissue

25 October 2025
Author(s): Sunil Upadhaya, Rohan Samson, Thierry H. Le Jemtel

In this issue of the European Journal of Internal Medicine, Calcaterra et al. wrote one of the most comprehensive reviews of Epicardial Adipose Tissue (EAT) [1]. In contrast to past dithyrambic EAT... more

From words to biomarkers: Why PEth should enter clinical practice when assessing the risk of venous thromboembolism

22 October 2025
Author(s): Elena Campello, Erika Zola, Paolo Simioni

Alcohol consumption remains one of the most pervasive and modifiable risk factors influencing global health. Its dualistic nature—protective in moderation, harmful in excess—has long fascinated... more

Prevention of venous thromboembolism in critically ill patients: current state and future perspectives

9 October 2025
Author(s): Valentine Mismetti, Patrick Mismetti, Laurent Bertoletti

Venous thromboembolic disease (VTE) is a major complication of intensive care, responsible for significant morbidity and mortality. It remains a constant challenge for clinicians because of the... more

Venous thromboembolism provoked by transient risk factors in women: Towards improved personalized risk assessment

1 October 2025
Author(s): Luuk J.J. Scheres, Jenneke Leentjens, Saskia Middeldorp

The occurrence of venous thromboembolism (VTE) in young women is a scenario frequently encountered in clinical practice. In this population, a VTE event is often associated with provoking risk... more

Treatment target of blood pressure: Changes in evidence-based guidelines and impact of measurement conditions

8 September 2025
Author(s): Kei Asayama, Takayoshi Ohkubo

Although exceptions exist, the general prognostic benefit of antihypertensive drug treatment is definite. With the accumulation of relevant evidence, the target blood pressure level of... more

Editorial

Management of patients without obstructive coronary arteries and suspected microvascular angina: Is it time for a paradigm shift?

29 November 2025
Author(s): Stefano De Servi, Antonio Landi, Bernardo Cortese

Up to 50 per cent of patients undergoing coronary angiography for suspected angina with evidence or not of myocardial ischemia have non-obstructed coronary arteries [1], a condition which is... more

Internal Medicine Flashcard

A 74-year-old man with skin thickening and ulcers

22 November 2025
Author(s): Ivânia Soares, Inês Pereira Amaral, Paulo Filipe

A 74-year-old man with hypertension, type 2 diabetes (HbA1c 12 %), and chronic kidney disease (KDIGO IIb) presented to the dermatology emergency department with an eight-month history of progressive... more

Recurrent vomiting

5 November 2025
Author(s): Ting Liao, Yuxia Zhu, Xi Liu

A 28-year-old male was referred to the Gastroenterology Department for a 6-year history of recurrent vomiting, occurring 2–3 times daily and exacerbating to >10 episodes per day following cold... more

Woman with progressed gait instability

4 November 2025
Author(s): Jia-Qi Chen, Wei-Nv Fan

An 81-year-old woman presented with progressed gait instability for several months. She had a temperature of about 37.5 °C. The initial neurological examination revealed unsteadiness on the finger-... more

Xanthelasma, arcus senilis, and supravalvular aortic stenosis

9 October 2025
Author(s): Ashishpreet Singh, Suraj Kumar, Bhupinder Singh

A 28-year-old female presented with 12 months of progressive dyspnea and 6 months of exertional angina, now limiting daily activities. On examination (Fig. 1; Panel A), she had xanthelasma, arcus... more

Bilateral ocular motility impairment

9 October 2025
Author(s): Keizo Tanitame, Nobuko Tanitame

An 82-year-old man was referred to the Diagnostic Imaging Center with progressive bilateral ocular motility impairment and diplopia, which had gradually worsened over the past three months, with... more

Ataxia, dysarthria and brainstem lesions in an elderly patient: a diagnostic challenge

25 August 2025
Author(s): Daniela Zermeño-Napolitano, Rodrigo Villaseñor-Echavarri, Latife Salame Khouri

A 75-year-old Hispanic man presented with a 3-year history of frequent falls conditioned by gait instability and generalized weakness. His symptoms progressed with worsening of gait imbalance,... more

Invited Review Article

Contemporary management of advanced chronic kidney disease: An evidence-based review

22 October 2025
Author(s): Lyle W. Baker, Cene Ovincy, Levon Souvalian, LaTonya J. Hickson, Fouad T. Chebib

Chronic kidney disease (CKD) is a growing global health burden, affecting over 850 million people worldwide and contributing substantially to cardiovascular morbidity, premature mortality, and... more

Letter to the Editor

Advancing beyond multimodality: integrating quantitative imaging biomarkers into the clinical workflow of cardiac amyloidosis

4 December 2025
Author(s): Yonghao Jiang, Suying Wu, Yuantong Xu

We read with great interest the comprehensive narrative review by Sinigiani et al. titled "Multimodality imaging for cardiac amyloidosis: clinical applications and future directions" published in the... more

West Nile virus infection: New guitars in town for the internal medicine community

4 December 2025
Author(s): Raffaella Gallo, Iolanda Cafarella, Fabian Patauner, Lorenzo Bertolino, Emanuele Durante-Mangoni

Dear Editor,

Clinical implications of the U-shaped association between body mass index and atrial tachyarrhythmia recurrence after paroxysmal atrial fibrillation ablation

3 December 2025
Author(s): Danni Huang, Linping Zhu

We read with great interest the article by Liao et al., which reported that both underweight and obese patients are at increased risk of atrial tachyarrhythmia (ATa) recurrence after catheter... more

Addressing gaps in inpatient diabetes management: A call for integrated multidisciplinary approaches

2 December 2025
Author(s): Lu Zhang, Peng Zhang

We commend Porth et al. for their timely and insightful study, "Gaps in Glycaemic Monitoring and Underuse of Cardioprotective Glucose-lowering Agents," which elucidates critical deficiencies in... more

Tirzepatide as adjunct to insulin for the treatment of type 1 diabetes

2 December 2025
Author(s): Dimitrios Patoulias, Eleftherios Teperikidis, Djordje S. Popovic, Paschalis Karakasis, Theocharis Koufakis

Based on the latest published data, global prevalence of type 1 diabetes (T1D) was 8.4 million individuals in 2021, with 18 % of them being younger than 20 years, 64 % aged 20–59 years and 19 % aged... more

Optimization and clinical applicability of monitoring strategies: further exploration of the monitoring of transient new-onset atrial fibrillation recurrence

2 December 2025
Author(s): Yanqiu Yang, Jie Gao, Xinkang Wang

We read with great interest the study by McIntyre et al. on the monitoring time and recurrence detection rate of transient new-onset atrial fibrillation (AF) [1]. The study provides valuable... more

Direct oral anticoagulant dose optimization in cancer-associated thrombosis: Current evidence and implications for extended therapy

30 November 2025
Author(s): Ursula Medeiros Araujo de Matos, Ursula Medeiros Araujo de Matos, Moana Divina Da Silva Santiago, Patrick Froelich Meldola, Swarup Kumar, Ritika Vankina

Cancer-associated thrombosis (CAT) remains a leading cause of morbidity and mortality. Important risk factors in this population include chemotherapy, hormonal therapies, indwelling catheters or... more

Inpatient diabetes management in Europe: The limits of a single-day snapshot

29 November 2025
Author(s): Binqi Wang, Ruikai Zhang, Juan Jin, Qiang He

We read with great interest the article by Porth et al. [1], titled "Gaps in Glycaemic Monitoring and Underuse of Cardioprotective Glucose-lowering Agents: Challenges of inpatient diabetes care... more

Body weight extremes and recurrence risk after ablation of paroxysmal atrial fibrillation

29 November 2025
Author(s): Jun Yang, Hanning Zhang

We read with great interest the recent article by Liao et al., entitled “Both underweight and obese patients are prone to relapse after ablation of paroxysmal atrial fibrillation” [1]. The authors... more

Antibiotic use in hospitalized older adults according to WHO AWaRe classification: data from the REPOSI register

25 November 2025
Author(s): Chiara Elli, Chiara Crippa, Luca Pasina, REPOSI, Investigators

Antimicrobial resistance is a growing global concern and represents a major threat to public health [1]. In response, many countries have implemented guidelines aimed at promoting the rational use of... more

Physical activity in systemic vasculitis

21 November 2025
Author(s): Jozélio Freire De Carvalho, Ana Tereza Amoedo Martinez, Thiago Teixeira Mendes

Dear Editor,

Cardiovascular siRNA therapeutics: A global clinical trial landscape analysis

21 November 2025
Author(s): Han Yan, Haorui Zha, Jiayi Chen, Zhenhui Wang, Linghua Pei

Dear Editor

Bronchoscopy, ventilator dose and outcomes in severe CAP: reading the sex signal

21 November 2025
Author(s): Yulin Liu, Lu Wang

We read with great interest the analysis conducted by Garin et al. regarding sex-related differences in adults intubated for severe community-acquired pneumonia within the EU VAP CAP platform, which... more

Beyond the algorithm: The human interface of medicine

20 November 2025
Author(s): Luca Bonanni, Ada Cutolo

“You should stand at the right side of the patient’s bed.” [1]

Cognitive impairment in familiar hypercholesterolemia: How much is vascular and how much is confounding? Author's reply

18 November 2025
Author(s): Sabrina Scilletta, Antonino Di Pino, Salvatore Piro, Roberto Scicali

We sincerely thank Messina et al. for their thoughtful and valuable comments regarding our study. We fully acknowledge the importance of the points raised and appreciate their contribution to the... more

Bridging the gap: Phenotype-specific considerations for rituximab therapy in IgG4-related disease

15 November 2025
Author(s): Jingyi Li, Jiamin Wang

We were pleased to read the recent article by Goni et al., entitled “Effectiveness and safety of rituximab across the four phenotypes of IgG4-related disease: a European multi-center cohort study of... more

Age, sex and DNAR: Re-evaluating the excess-mortality paradox in nonagenarian ICU patients. Author’s reply

14 November 2025
Author(s): Frederik Peters, Jan Frederic Weller, Kevin Roedl, Liesbeth de Wreede, Maximilian Christopeit

Dear Editor,

Mepolizumab improves health-related quality of life in patients with hypereosinophilic syndrome

14 November 2025
Author(s): Florence Roufosse, Maria C Cid, Arunangshu Biswas, Yekaterina Poloz

Hypereosinophilic syndrome (HES) is a rare, heterogeneous disorder, characterised by high eosinophil levels (≥1500 cells/µL) and eosinophilic inflammation leading to multiorgan dysfunction and damage... more

Considerations on socioeconomic and hormonal factors in sex- and gender-specific risk of metabolic syndrome

11 November 2025
Author(s): Aysun Isiklar

We read with great interest the article by Alipour et al. entitled “Role of sex and gender-related variables in development of metabolic syndrome” published in the European Journal of Internal... more

Heart failure with preserved ejection fraction in older inpatients: Where diagnostic algorithms meet geriatric reality

10 November 2025
Author(s): Roberto Presta, Enrico Brunetti, Francesco Palmas, Mario Bo

Heart failure with preserved ejection fraction (HFpEF) represents a growing and increasingly prevalent phenotype of heart failure (HF) in older adults, yet its recognition in routine clinical... more

Anifrolumab for refractory dermatomyositis: Experience from a Spanish cohort

4 November 2025
Author(s): Jorge Álvarez Troncoso, Elena Sendagorta Cudos, Esther Fiz Benito, Ismael Calero Paniagua, Ángel Robles Marhuenda

Dermatomyositis (DM) frequently remains active despite glucocorticoids and conventional immunosuppressants. A type I interferon (IFN-I) gene-expression signature across skin, muscle, and blood... more

Left ventricular remodeling in IgA nephropathy — clinical applicability and lessons from real-world practice

4 November 2025
Author(s): Binqi Wang, Juan Jin, Qiang He

I read with great interest the study by Jin[1], which examines the prognostic implications of distinct left ventricular (LV) geometric patterns in patients with biopsy-proven IgA nephropathy (IgAN).... more

Managing psoriasis in patients with lupus: A complex challenge

3 November 2025
Author(s): Margarida Lucas Rocha, Ivânia Soares, Vítor Silvestre-Teixeira, Paulo Filipe

Psoriasis is a common, chronic, and relapsing scaly erythematous skin disease, occurring worldwide at any age, with no clear gender predilection. It shows a bimodal age distribution, with incidence... more

Activation state of peripheral T lymphocytes predicts response to abatacept in patients with IgG4-related disease

3 November 2025
Author(s): Claudia Minici, Jasmin Mahajne, Ugo Orfanelli, Marco Lanzillotta, Emanuel Della-Torre

Dear Editor,

Cognitive impairment and vascular injury in familial hypercholesterolemia: Looking beyond the association

3 November 2025
Author(s): Wei Cui, Yiguo Chen, Zedong Cheng

We read with great interest the article by Sabrina Scilletta et al. published in the European Journal of Internal Medicine, which explored the relationship between cognitive function and subclinical... more

Methodological considerations for interpreting the association between central systolic blood pressure and brain health

3 November 2025
Author(s): Hui Chen

We read with great interest the recent article by Yu et al. (2025) [1] in the European Journal of Internal Medicine, which investigated the association between central systolic blood pressure (cSBP... more

Utility of following morning body weight in patients with hyponatremia due to chronic SIAD

30 October 2025
Author(s): Guy Decaux, Alain Soupart

In patients with chronic hyponatremia, SNa must be maintained above 134 mEq/l to minimize associated morbidity [1].

Traceability of point-of-care ultrasound: The PACS integration process in a tertiary hospital

28 October 2025
Author(s): Yale Tung-Chen, Paloma Oliver, David Castrillo Lázaro

Point-of-Care Ultrasound (POCUS) has become established as an essential diagnostic and therapeutic tool in Internal Medicine, Emergency Medicine, Geriatrics, and other care settings. It allows... more

Tezepelumab in severe asthma: Strengthening real-world evidence and addressing unresolved clinical questions

28 October 2025
Author(s): Jiamin Wang, Jingyi Li

We were pleased to read the recent article by Poto et al. entitled “Effectiveness of tezepelumab in severe asthma: A multicenter real-world study,” published in the European Journal of Internal... more

Meta-analysis of the relationship between internal microplastic and health outcomes

25 October 2025
Author(s): Xiao Liu, Jiaxue Xu, Zexuan Wang, Haisheng Wu, Peng Yu

Dear editor,

Understanding the threat of West Nile virus infection. Comment on prevention and therapy

10 October 2025
Author(s): Salvatore Chirumbolo, Luigi Valdenassi, Umberto Tirelli, Marianno Franzini

We read with interest the article from Gallo et al., which provides a clear and structured overview of the West Nile virus (WNV), particularly valuable for clinicians unfamiliar with its clinical... more

Authors of individual participant data meta-analyses must honor trialists’ commitments to trial participants: a case study

10 October 2025
Author(s): Rafael Dal-Ré

The need to respect the trial participants’ willingness regarding the secondary use of their data to conduct research such as meta-analyses has been recently discussed [1]. The best approach is to... more

Severe acute refractory hyperkalaemia associated with liposomal amphotericin B infusion

7 October 2025
Author(s): Gabriëlla von Kreijfelt, Linda Davidson, Yara Joanne Holtrust, Maarten Arends, Juliëtte Zwaveling

Dear editor,

Bolus or continuous for AHF? Lessons from DIUR-AHF. Author's reply

6 October 2025
Author(s): Andrea Salzano, Giulia Crisci, Alberto Palazzuoli

On behalf of the DIUR-AHF investigators, we thank Zhai and Sun for the attention on our research [1] and for the interesting comments provided in their letter to the editor, published in the present... more

Pharma’s subtle conditioning in clinical medicine

5 October 2025
Author(s): Nicola Mumoli, Lucia Colavolpe, Francesco Cei

The relationship between physicians and the pharmaceutical industry continues to provoke debate, often framed around conflicts of interest and the potential for undue influence on prescribing... more

Association between sPESI score and 90-day hospital readmissions in patients with acute pulmonary embolism

29 September 2025
Author(s): Kwadwo O. Bonsu, Rufaro S. Chitsike, Tiffany A. Lee, Hai V. Nguyen, Stephanie W. Young

Pulmonary embolism (PE) is a leading cause of cardiovascular morbidity and mortality, with 10–30 % of patients dying within one month of diagnosis [1]. Early risk stratification can aid clinicians in... more

Association of prevalence of hypertension and its subtypes with short-term weight change

24 September 2025
Author(s): Haonan Li, Jieying Shi, Jialin Wen, Juan Luo, Yi Zhang

Obesity is a well-established risk factor for hypertension, and produces various hemodynamic abnormalities that may impact hypertension subtypes [1]. From 2011 to 2020, obesity prevalence in the US... more

Age, sex and DNAR: Re-evaluating the excess-mortality paradox in nonagenarian ICU patients

15 September 2025
Author(s): Renyi Zhu, Jianmin Qu

We read with interest Weller and colleagues’ elegant demonstration that chronological age alone is not associated with excess mortality among nonagenarian ICU patients [1]. Their use of relative-... more

Beyond eligibility – the relevance of individualized heart failure therapy across specialties

12 September 2025
Author(s): Henning Johann Steffen, Tobias Schupp

We read with interest the article by Gencher et al., investigating specialty-related differences in the implementation of guideline-directed medical therapy (GDMT) for patients hospitalized with... more

Aetiology of inflammatory abdominal aortic aneurysms influences prognosis

5 September 2025
Author(s): Océane Rieux, Marie Morard, Antoine Benichou, Loubna Dari, Olivier Espitia

Abdominal aortic aneurysms (AAA) affect approximately 5 % of male over the age of 65 [1]. Among these, 5 % to 10 % are classified as inflammatory AAA (IAAA) [2]. A wide range of underlying... more

Bolus or continuous for AHF? lessons from DIUR-AHF

5 September 2025
Author(s): Yuxiao Zhai, Yinghan Sun

With keen interest, we have read the DIUR-AHF study published by Palazzuoli et al. [1], which provides important real-world evidence on loop diuretic strategies in acute heart failure (AHF). The... more

Association of social isolation with excess mortality risk and life expectancy in people with prediabetes and diabetes

27 August 2025
Author(s): Rui Chen, Ying Zhou, Xiaoxv Yin

Diabetes affects 589 million adults globally and significantly increases mortality risk by 1.6- to 2-fold, with an additional 1.1 billion people estimated to have early-stage glucose metabolism... more

Potassium instability and prognosis in acute heart failure: Practice-oriented reflections

25 August 2025
Author(s): Shaoxiang Huang, Xueyu Wang, Peili Zhang

We read with interest the article, “Association between serum potassium variability during admission for decompensated heart failure and outcomes,” published in the European Journal of Internal... more

Critical considerations on sTREM2 as a biomarker for early MASH in women with severe obesity

21 August 2025
Author(s): Jingyi Li, Xizhuang Gao

We commend Mahmoudian et al. for their insightful study investigating soluble TREM2 (sTREM2) as a noninvasive biomarker for early metabolic dysfunction-associated steatohepatitis (MASH) in women with... more

Phosphatidylethanol and venous thromboembolism risk – clinical implications and future directions

19 August 2025
Author(s): Daniel Matovu

I read with great interest the prospective study by Johansson et al. [1] published in the European Journal of Internal Medicine, which investigates the association between phosphatidylethanol (PEth)... more

Optimizing potassium control in hospitalized heart failure patients: Unanswered questions and future perspectives

18 August 2025
Author(s): Siyu Feng, Quan Zhou, Huaqiang Xu

We read with great interest the recent article by Suzuki et al., recently published in the European Journal of Internal Medicine [1]. The authors address an important and often overlooked aspect of... more

Not just the level – the importance of potassium stability in patients with heart failure

9 August 2025
Author(s): Tobias Schupp, Ibrahim Akin, Michael Behnes

We read with great interest the manuscript by Suzuki et al. investigating the prognostic impact of changes of serum potassium levels during index hospitalization in a large cohort of 1280 patients... more

DOACs vs. VKAs for renal protection: An established superiority gives rise to a new clinical paradox

18 July 2025
Author(s): Ahmed B. Shamsulddin

I commend Adamou and colleagues for their important meta-analysis, which reinforces the established superiority of direct oral anticoagulants (DOACs) over vitamin K antagonists (VKAs) for preserving... more

Original Article

Fractional exhaled nitric oxide in acute exacerbations of chronic obstructive pulmonary disease: A meta-analysis with meta-regressions

28 November 2025
Author(s): Pasquale Ambrosino, Claudio Candia, Stefano Sanduzzi Zamparelli, Giuseppina Marcuccio, Fabio Manzo, Giorgio Alfredo Spedicato, Christian Basile, Costantino Mancusi, Ennio Lubrano, Guido Grassi, Andrea Motta, Mauro Maniscalco

Fractional exhaled nitric oxide (FeNO) has emerged as a useful tool for monitoring airway inflammation in chronic obstructive pulmonary disease (COPD) patients. We designed a systematic review and... more

Robustness of randomized controlled trial evidence for SGLT2 inhibitors in heart failure with preserved and mildly reduced ejection fraction

27 November 2025
Author(s): Marco Zuin, Pierluigi Temporelli, Claudio Bilato, Alberto Corsini, Fabrizio Oliva, Gianluigi Savarese, Raffaele De Caterina

Sodium–glucose co-transporter 2 inhibitors (SGLT2i) have emerged as a fundamental therapy for patients with heart failure with preserved ejection fraction (HFpEF), a population that has historically... more

Effects of calcium channel blockers on GDMT prescription and outcomes according to ejection fraction: IN-HF real world data

12 November 2025
Author(s): Mauro Gori, Luca Fazzini, Jennifer Meessen, Raul Limonta, Samuela Carigi, Matteo Bianco, Luisa De Gennaro, Concetta Di Nora, Paolo Manca, Maria Vittoria Matassini, Vittoria Rizzello, Denitza Tinti, Aldo Pietro Maggioni, Francesco Orso, Marco Gorini, Renata De Maria, Italian Network on Heart Failure (IN-HF) Investigators

Dihydropyridine calcium channel blockers (DHP-CCB) are widely used in heart failure (HF), despite the lack of data regarding their safety, especially in patients with reduced ejection fraction (HFrEF... more

Gaps in Glycaemic Monitoring and Underuse of Cardioprotective Glucose-lowering Agents: Challenges of inpatient diabetes care identified by EFIM’s Diabesity Day Survey 2024

8 November 2025
Author(s): Ann-Kristin Porth, Anete Palma, Burcu Sallarel, Dimitrios Patoulias, Dirk Müller-Wieland, Dror Dicker, Ieva Ruža, Ilya Davidenko, Jan Škrha, Julia Brandts, Ricardo Gomez-Huelgas, Shiran Gruber, Sindija Smirnova, Theocharis Koufakis, Yusuf Ziya Sener, Zuzana Kršáková, Alexandra Kautzky-Willer, EFIM Diabetes and Obesity Working Group

People with diabetes and people with obesity have an increased risk of hospitalisation, tend to have longer hospital stays, and have higher mortality when hospitalised (1–3). Diabetes management... more

Both underweight and obese patients are prone to relapse after ablation of paroxysmal atrial fibrillation

25 October 2025
Author(s): Yu Liao, Chintan Trivedi, Michela Casella, Sanghamitra Mohanty, Luigi Di Biase, Selene Cellucci, Momen Ibrahim, Tejas S Khurana, Wilber Su, J. Peter Weiss, Michael Zawaneh, Antonio Dello Russo, Changsheng Ma, Claudio Tondo, Andrea Natale, Rong Bai

Being overweight has been associated with arrhythmia recurrence after atrial fibrillation (AF) ablation, but the optimal threshold to identify high risk patients has not been well established.... more

Association between long-term exposure to PM10 and metabolic dysfunction-associated steatotic liver disease (MASLD) in subjects with disturbed metabolic homeostasis and genotypes at risk

18 October 2025
Author(s): Agostino Di Ciaula, Marcin Krawczyk, Susanne N. Weber, Mohamad Khalil, Jerlin Stephy JohnBritto, Hala Abdallah, Piero Portincasa

Poor information exists on the role of air pollutants as possible predictors of liver fat over-storage in subjects with increased clinical and genetic risk for MASLD.

Evaluation of the concordance between clinical diagnosis and biopsy in cutaneous vasculitis

14 October 2025
Author(s): Deiner-Yivelson Muñoz-Delgado, Julián-Esteban Barahona-Correa, Daniela Meléndrez-Vásquez, Isabel-Cristina Cuellar-Ríos, Martín-Alonso Rondón-Sepúlveda, Daniel G. Fernández-Ávila, Santiago Bernal-Macías

Cutaneous vasculitis poses a diagnostic challenge due to its variable presentations and overlap with other dermatologic conditions. Although biopsy is essential for confirmation, the concordance... more

Left ventricular remodeling in IgA nephropathy: Prognostic implications and clinical correlations

11 October 2025
Author(s): Lu-Hua Jin, Qian Zhou, Gui-Xin Huang, Yi-Qin Wang, Peng-An Li, Li Tan, Wei Chen, Qiong Wen

The determinants and prognosis of left ventricular (LV) geometric remodeling remain uncharacterized in immunoglobulin A nephropathy (IgAN). We investigated the (1) clinicopathological correlates of... more

Monitoring time-to-detection of recurrent atrial fibrillation in patients with transient new-onset atrial fibrillation detected initially during hospitalization for noncardiac surgery or medical illness

9 October 2025
Author(s): William F. McIntyre, Linda S. Johnson, Alexander P. Benz, Maria E. Vadakken, Nicole R. Latendresse, Chinthanie Ramasundarahettige, Faith Kirabo, Jorge A. Wong, Jason D. Roberts, Jeff S. Healey

Approximately one-third-of patients with transient new-onset atrial fibrillation (AF) during hospitalization for noncardiac surgery or medical illness will have recurrent AF within 1 year when... more

Endothelin-1 as dual marker for renal function decline and associated cardiovascular complications in patients with chronic kidney disease

8 October 2025
Author(s): Laura González-Rodríguez, Manuel Martí-Antonio, Sonia Mota-Zamorano, Celia Chicharro, Bárbara Cancho, Enrique Luna, Álvaro Álvarez, Zoraida Verde, Fernando Bandrés, Nicolás R Robles, Guillermo Gervasini

Cardiovascular (CV) complications are the leading cause of death in patients with chronic kidney disease (CKD). Endothelin-1 (ET-1), a potent vasoconstrictor involved in both renal and vascular... more

Prognostic role of TAPSE/PASP ratio among older patients with acute heart failure and preserved ejection fraction

7 October 2025
Author(s): Giuseppe De Matteis, Amato Serra, Maria Livia Burzo, Francesco De Vito, Maria Anna Nicolazzi, Antonio Iaconelli, Antonio Gasbarrini, Francesco Franceschi, Giovanni Gambassi, Marcello Covino

Right ventricular (RV)-pulmonary circulation (PC) uncoupling is associated with poor outcome in patients with Heart Failure with Preserved Ejection Fraction (HFpEF). Tricuspid annular plane systolic... more

Cardiovascular-kidney-metabolic domains and impact on antithrombotic treatment, integrated care and clinical outcomes in patients with atrial fibrillation: results from a prospective European registry

30 September 2025
Author(s): Davide Antonio Mei, Jacopo Francesco Imberti, Marco Vitolo, Giulio Francesco Romiti, Bernadette Corica, Marta Mantovani, Niccolò Bonini, Benedetta Cherubini, Francisco Marin, Igor Diemberger, Gheorghe Andrei Dan, Tatjana Potpara, Marco Proietti, Gregory Y.H. Lip, Giuseppe Boriani

Cardiovascular, kidney, and metabolic (CKM) conditions frequently coexist with atrial fibrillation (AF), but their impact in AF population remains poorly characterized.

Non-cardiac surgeries in adults with congenital heart disease -influence of complexity of disease and estimated risk of surgery on adverse events

26 September 2025
Author(s): Alicia Jeanette Friedrich, Robert Radke, Stefan Orwat, Gerrit Kaleschke, Philipp Darius Garthe, Fernando de Torres-Alba, Kevin Willy, Joachim Gerß, Helmut Baumgartner, Gerhard-Paul Diller, Jeanette Köppe

To provide information on adults with congenital heart disease (ACHD) undergoing non-cardiac surgeries (NCS), specific risk compared non-ACHD, independent risk factors for adverse outcome and... more

Short and long term effects of a two-week transcutaneous vagus nerve stimulation in hyperadrenergic postural orthostatic tachycardia syndrome: a proof-of-concept trial

26 September 2025
Author(s): Dana Shiffer, Stefano Rigo, Maura Minonzio, Deniz Timothy Yarsuvat, Eleonora Tobaldini, Ludovico Furlan, Nicola Montano, Beatrice Cairo, Alberto Porta, Antonio Roberto Zamunér, Stefanos Bonovas, Vasile Urechie, Italo Biaggioni, André Diedrich, Raffaello Furlan

autonomic nervous system

Effectiveness of tezepelumab in severe asthma: A multicenter real-world study

26 September 2025
Author(s): Remo Poto, Gianluca Manganello, Antonio di Salvatore, Ludovica Capitelli, Gianluca Lagnese, Carla Messuri, Tommaso Muto, Fausto De Michele, Gilda Varricchi

Severe asthma is a complex, heterogeneous disease that remains a major therapeutic challenge. Despite several biologics targeting type 2 (T2) inflammation, some patients remain uncontrolled,... more

Prognostic impact of left ventricular dilatation in heart failure with mildly reduced ejection fraction

16 September 2025
Author(s): Henning Johann Steffen, Michael Behnes, Jonas Dudda, Alexander Schmitt, Noah Abel, Felix Lau, Marielen Reinhardt, Thomas Bertsch, Kathrin Weidner, Daniel Duerschmied, Ibrahim Akin, Tobias Schupp

This study investigated the prognostic value of left ventricular (LV) dilatation in patients with heart failure with mildly reduced ejection fraction (HFmrEF).

Evaluation of cognitive profile and subclinical vascular damage in subjects with genetically confirmed familial hypercholesterolemia

15 September 2025
Author(s): Sabrina Scilletta, Nicoletta Miano, Maurizio Di Marco, Marco Musmeci, Salvatore Carasi, Stefania Capuccio, Claudia Pistritto, Caterina Ippolito, Mariapaola Tiralongo, Antonio Ricci, Maria Chiara Papa, Giosiana Bosco, Francesco Di Giacomo Barbagallo, Antonino Di Pino, Salvatore Piro, Roberto Scicali

Familial hypercholesterolemia (FH) is a genetic lipid disorder characterized by lifelong exposure to high levels of LDL cholesterol (LDL-C), which promotes the progression of atherosclerosis and... more

The Implementation of the Acute Basic Palliation Concept in Newly introduced Hospital Departments: An Explorative Observational Study of Non-Specialized Palliative Patients Discharged to Die at Home in Denmark

29 August 2025
Author(s): Dorte Melgaard, Matilde Alida Arendt Eriksen, Jakob Fogh Jørgensen, Harman Yonis, Rikke Bramming, Laurits Dalsgaard, Camilla Ly, Bensu Izgi, Annika Kamp, Natasja Uldall, Luise Lilleøre, Maiken Faklam Dalsgaard Knudsen, Marte Brenna Steinbakken, Christian Bille, Kalle Lindbjerg, Julie Bjerke, Abeda Samadi, Anne Lund Krarup

Palliative Care (PC) is a key component of patient-centred healthcare, focusing on relieving the symptoms, pain, dignity and stress of patients with serious, life-limiting conditions. A widely... more

Sex differences in venous thromboembolism outcomes: findings from the GARFIELD-VTE registry

25 August 2025
Author(s): Paolo Prandoni, Meg Fluharty, Sebastian Schellong, Henri Bounameaux, Sylvia Haas, Lorenzo G Mantovani, Sherif Sholkamy, Katsuhiro Kondo, Harry Gibbs, Zhi-Cheng Jing, Chern-En Chiang, Peter Verhamme, Alexander GG Turpie, Jeffrey I. Weitz, Walter Ageno, Shinya Goto, Pantep Angchaisuksiri, Karen Pieper, Ajay K Kakkar, GARFIELD-VTE Investigators

Venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT), is a major cause of morbidity and mortality [1] VTE is linked to several risk factors, including age,... more

Impact of a Checklist-Based Strategy for Cardiac Amyloidosis Screening on Diagnosis Rates in Heart Failure Patients (CHECKAMIC Study)

21 August 2025
Author(s): Alberto Pérez-Nieva, Pau Llàcer, Prado Salamanca-Bautista, Miquel Camafort, Marina García-Melero, Rocio Ruiz-Hueso, Ana Suárez, Carlos Pérez, Irene Bravo-Candela, Raul Ruiz, Anna Aldea, Genoveva López, Cristina Fernández, María del Prado Orduña, Martín Fabregate, Oscar Aramburu-Bodas, Luis Manzano

Amyloidosis is a storage disease caused by the extracellular deposition of fibers derived from structural alterations of unstable proteins, which after folding and aggregation are finally deposited... more

An exploratory model for short-term risk stratification in intermediate-high-risk pulmonary embolism running head: The STAMP score

20 August 2025
Author(s): Marco Zuin, Claudio Bilato, Iolanda Enea, Amedeo Bongarzoni, Franco Casazza, Loris Roncon, Cecilia Becattini

Patients with acute pulmonary embolism (PE) characterized by hemodynamic stability, evidence of right ventricular (RV) dysfunction (RVD), positive cardiac biomarkers and high simplified pulmonary... more

Effectiveness and safety of rituximab across the four phenotypes of IgG4-related disease: a European multi-center cohort study

19 August 2025
Author(s): Elisabetta Goni, Jens Vikse, Marco Lanzillotta, Bjørg-Tilde Svanes Fevang, Øyvind Midtvedt, Jasmin Mahajne, Veronica Batani, Giovanni Benanti, Georg Beyer, Lorenzo Dagna, Øyvind Molberg, Katrine Brække Norheim, Ulf Schönermarck, Ivonne Regel, Julia Mayerle, Anna-Maria Hoffmann-Vold, Emanuel Della-Torre

IgG4-related disease (IgG4-RD) is a systemic fibroinflammatory condition with marked clinical heterogeneity [1]. Common manifestations include autoimmune pancreatitis and cholangitis, orbital... more

Long term fluid volume fluctuations and mortality in kidney failure patients on long term hemodialysis treatment

16 August 2025
Author(s): Carmine Zoccali, Giovanni Tripepi, Paola Carioni, Francesca Mallamaci, Matteo Savoia, Len A. Usvyat, Franklin W. Maddux, Stefano Stuard

The prognosis of patients kidney failure (KF) patients on long term hemodialysis treatment is one of the most severe among chronic diseases, and only modest progress has been made over the last... more

Bleeding risk on rivaroxaban versus apixaban in older patients with venous thromboembolism: a nationwide observational register-based study

11 August 2025
Author(s): Maria Roupe, Annika Rosengren, Aldina Pivodic, Rebecka Bertilsson, Jacob Philipson, Kristina Svennerholm, Mazdak Tavoly, Katarina Glise Sandblad

During primary treatment, apixaban was associated with a lower risk of major bleeding than rivaroxaban without a corresponding increase in recurrent PE risk. During secondary treatment, no difference... more

Venous thromboembolism associated with infections: a systematic review and meta-analysis

7 August 2025
Author(s): Panagiotis Stathopoulos, Stelios-Elion Bousi, Marinos Zachiotis, Athanasios Lampropoulos, Stylianos A. Kakoullis, Charalambos Michaeloudes, Matthew E. Falagas

Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), has long been a significant cause of severe disease and death. At the same time, its etiology is... more

A prospective study of the association between phosphatidylethanol concentration and risk of first-ever venous thromboembolism

2 August 2025
Author(s): Magdalena Johansson, Anders Själander, Marcus M Lind, Lars Johansson

Venous thromboembolism (VTE) is a common term for deep vein thrombosis (DVT) and pulmonary embolism. The overall incidence rate of VTE in adults is 1–2 per 1000 person-years and has increased... more

Transthyretin serum levels and clinical outcomes in patients with transthyretin amyloid cardiomyopathy

29 July 2025
Author(s): Annamaria Minervini, Gonzalo Barge-Caballero, Andrea López-López, Manuel López-Pérez, Eva González-Babarro, Inés Gómez-Otero, Raquel Bilbao-Quesada, Mario Gutiérrez-Feijoo, Alfonso Varela-Román, Alberto Bouzas-Mosquera, María G. Crespo-Leiro, Eduardo Barge-Caballero

Over the last decade, significant advances have been made regarding the knowledge of the biological bases, diagnosis and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM), which currently... more

Whether an optimal strategy exists for VTE prevention in critically ill patients: Insights from guidelines and randomized controlled trials

25 July 2025
Author(s): Di Wei, Sinan Ma, Weijia Huang, Ting Yang, Keyu Chen, Baoni Sun, Xinye Li, Li Zhang, Yan Wang

Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a significant concern in critically ill patients. Effective prevention is vital due to its high... more

Performance of enhanced liver fibrosis test and indirect serum fibrosis markers for exclusion of advanced liver fibrosis in alpha-1 antitrypsin deficiency

24 July 2025
Author(s): Naomi N. Kappe, Malin Fromme, Jan Stolk, Ilaria Ferrarotti, Pavel Strnad, Bart van Hoek

Alpha-1 antitrypsin deficiency (AATD) is a hereditary condition caused by mutations in the SERPINA1 gene, encoding alpha-1 antitrypsin (AAT), an important antiprotease in the lungs that is primarily... more

Baseline risk and outcome benefit from intensive blood pressure targeting. A systematic review

16 July 2025
Author(s): Paolo Verdecchia, Fabio Angeli, Gianpaolo Reboldi

The definition of blood pressure (BP) targets in treated hypertensive patients remains controversial. Some Guidelines recommend an ideal systolic BP target of <140 mmHg, with different targets... more

Venous thromboembolism associated with weak transient risk factors in young women: risk of late recurrence. An international cohort study

12 July 2025
Author(s): Victoria Bitsadze, Mariya Gennadevna Nikolaeva, Eve Mousty, Jamilya Khizroeva, Jeremy Laurent, Sylvie Ripart, Lorris Le Collen, Salim Allal, Mathieu Fortier, Sylvie Bouvier, Mathias Chea, Antonia Perez-Martin, Alexander Makatsariya, Jean-Christophe Gris

After a first episode of venous thromboembolism (VTE) treated according to the guidelines, the risk of thrombotic recurrence must be assessed in order to guide medical treatment. The clinical risk... more

Review Article

The neuro-cardiac axis in epilepsy

4 December 2025
Author(s): Theodora A. Manolis, Antonis A. Manolis, Apostolos Vouliotis, Antonis S. Manolis

Epilepsy is one of the major noncommunicable neurological disorders (the other comprising migraine, Alzheimer disease/other dementias, Parkinson’s disease, motor neuron diseases, multiple sclerosis,... more

The evolving landscape of screening, management and treatment strategies of aortic stenosis in ATTR amyloidosis

28 November 2025
Author(s): Aldostefano Porcari, Matteo Serenelli, Rossana Bussani, Gianfranco Sinagra, Lucia Venneri

Transthyretin amyloid cardiomyopathy (ATTR-CM) and aortic stenosis (AS) frequently coexist in elderly patients, particularly men, creating a complex clinical scenario with overlapping symptoms and... more

Cardiovascular Risk Assessment: Practical Tips for the Internal Medicine Specialist

23 November 2025
Author(s): Fernando A. Rivera, Ridwan Ahmad, Jorge Trejo-Gutierrez

Cardiovascular diseases remain the leading cause of mortality worldwide, and they also represent a significant burden in terms of health care expenditure, equipment use, therapeutic interventions and... more

Frailty measurement in research and clinical practice: An updated review

20 November 2025
Author(s): Elsa Dent, Peter Hanlon, Paul Kowal, Emiel O. Hoogendijk

Frailty is a highly prevalent geriatric condition, affecting between 12–24% of older adults globally. It remains a major cause of morbidity and mortality in older adults. Incorporating frailty... more

Drug-induced rise in serum creatinine: cystatin C to the rescue? Evidence, pitfalls and knowledge gaps

11 November 2025
Author(s): Elliott Van Regemorter, Eléonore Ponlot, Lidvine Boland, Valentine Gillion, Arnaud Devresse

Serum creatinine (SCr) concentration is a cheap biomarker of kidney function measured globally millions of times every day. It is part of the KDIGO definitions of both chronic kidney disease and... more

Multidisciplinary strategies and new technologies in the management of sarcoidosis

31 October 2025
Author(s): Claudio Tana, Marjolein Drent, Ogugua Ndili Obi, Francesco Cinetto, Nicol Bernardinello, Livia Moffa, Marco Tana, Dominique Israël Biet, Paolo Spagnolo

Sarcoidosis exemplifies the complexity of modern internal medicine, requiring comprehensive, system-based management. The disease is characterized by non-caseating granulomas and can affect virtually... more

Multimodality imaging for cardiac amyloidosis: clinical applications and future directions

29 October 2025
Author(s): G Sinigiani, L De Michieli, S Nistri, D Cecchin, D Mele, A Cipriani

Systemic amyloidosis are a group of disorders characterized by the extracellular deposition of misfolded protein fibrils [1]. When the heart is involved, the condition is referred to as cardiac... more

ANCA-associated vasculitis and interstitial lung disease: challenges and open questions

20 October 2025
Author(s): Sergio Prieto-González, Raül Jordà-Sánchez, Fernanda Hernández-González, Rona M Smith, David RW Jayne

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a systemic inflammatory disorder that primarily affects small blood vessels, often involving vital organs such as the... more

Crystal clear – Part II: the role of uric acid in cardiorenal disease

17 October 2025
Author(s): Claudio Borghi, Federica Fogacci, Arrigo FG Cicero

Building on the foundational mechanistic and epidemiological knowledge from Part I, this second part of the review further unpacks the cardiovascular implications of abnormalities in serum levels of... more

Anemia in cardiorenal disease: From pathogenesis to treatment

15 September 2025
Author(s): Juan Heng, Zhong-Tang Li, Dan-Dan Yao, Xin-Yan Li, Ming-Xuan Cui, Zuo-Lin Li

Chronic kidney disease (CKD) is a highly prevalent, and progressive comorbidity that affects >10 % of the population worldwide [1–2]. Heart failure (HF) is also a common, disabling, and deadly... more

Earlier Prediction of Cardiovascular Risk with Epicardial Fat Assessment

22 August 2025
Author(s): Giuseppe Calcaterra, Ron T. Varghese, Maurizio Baroni, Alessandro Capucci, Fabio Angeli, Gianluca Iacobellis, Paolo Verdecchia

Obesity is no longer considered a cosmetic problem. The World Health Organisation (WHO) and the European Parliament, as well as many international medical and scientific societies, have recognised... more

Fever and inflammation of unknown origin in the 21st century

20 August 2025
Author(s): Christina Antoniadou, Efstratios Gavriilidis, Petros Chatzopoulos, Maria Gkouliavera, Panagiotis Skendros

Fever of unknown origin (FUO) and inflammation of unknown origin (IUO) are among the most complex and challenging clinical syndromes in Internal Medicine. Internists, by virtue of their broad... more

Charting the future of AL amyloidosis: Diagnostic advancements, prognostic insights, and therapeutic challenges

8 August 2025
Author(s): Xiayin Li, Jiecong Wu, Qing Huang, Wanting Zheng, Lu Huang, Changhao Han, Chunyu Zhang, Zhichun Gan, Yan Xing, Shiren Sun

Light-chain (AL) amyloidosis is a form of plasma cell dyscrasias characterized by deposition of misfolded monoclonal immunoglobulin light chain-derived amyloid fibrils, resulting in abnormal... more

Crystal clear – part I: The role of uric acid in cardiorenal disease

27 July 2025
Author(s): Claudio Borghi, Federica Fogacci, Arrigo FG Cicero

Uric acid (UA), the terminal product of purine catabolism in humans, arises from both endogenous nucleic acid turnover and exogenous sources—particularly diets rich in animal protein and fructose.... more

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness